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Storing CF TissuesIn 2001, a major scandal at a children’s hospital in These issues have a direct implication for CF and otherEngland captured the attention of the media and politicians.
A pathologist, Dick van Velzen, had hoarded hundreds of
organs and body parts from dead children, and they were
discovered intact some years after he had left the hospital.
Van Velzen had filed autopsy reports on these children,
including detailed histology, but many of the organs had
never been sectioned. It emerged that formal consent for
retention of the organs had not been obtained, and under-
standably many of the bereaved parents were angry. The
subsequent Government enquiry [1] and the sense of public
outrage have had far-reaching and adverse effects not only
for paediatric pathology but also for all medical research
which involves the study of stored human tissue, and at the
time of writing new UK legislation restricting the use of
such tissue is awaiting confirmation. The events at Alder
Hey came at a time when public interest in medicine was
increasing, while at least in the UK, trust in its practitioners
seemed to be decreasing. With better education about health
issues and patients’ rights worldwide, people who agreed to
take part in research projects were rightly demanding
detailed explanation of what exactly they had consented
to, including what use would be made of blood, tissue or
DNA samples which they were contributing to the study.
For some, it came as a surprise that scientists do not always
know where their research may lead, and that fibroblasts,
blood samples or DNA might end up having additional tests
which were not envisaged when the consent was obtained.
Storage of samples is essential unless the researchers (or
their successors) are willing and able to trace the donors and
obtain further material sometimes years later—when they
may have died or emigrated. In addition to its research
potential, analysis of stored samples could be immensely
important to the donor’s immediate relatives or descendants.1569-1993/$ - see front matter D 2004 Published by Elsevier B.V. on behalf of E
doi:10.1016/j.jcf.2004.06.001genetic research, and for the very existence of tissue banks
and networks. For this reason, the paper by Dr Trouet and
her colleagues (page. . .) is timely, and it provides a model
consent form which can be used as a guide for other
institutions [2]. It has been approved by CF organisations
representing patients’ interests and comes from a depart-
ment of legal studies which is conversant with European as
well as national laws. Its principles of informed consent and
protection of privacy are universally applicable and should
safeguard the interests of the scientists as well as those of
people with CF and their families. Clinicians are usually
involved in obtaining consent from patients, and whenever
it is possible that biopsies, cells or other samples might be
stored for future study—perhaps for tests which have not yet
been invented—they should consider using a consent form
of this type. It could also be modified for use in neonatal
screening programmes using dried blood spots. That is why
this unusual, but very useful paper has been published in the
Journal. As they say, the authors will be pleased if their
work facilitates your research.References
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